Oscar Health Inc. Reports Q3 Results
Oscar Health Inc. (NYSE: OSCR) has unveiled its financial results for the third quarter. The healthcare technology firm experienced a year-over-year revenue increase, reporting approximately $2.99 billion, compared to $2.4 billion from the previous year. However, this result did not meet the expected consensus estimate of $3.08 billion, reflecting challenges the company may be facing in its growth trajectory.
Membership Increases, Yet Losses Widen
The company saw a significant surge in membership, jumping from 1.65 million to roughly 2.12 million within this quarter. This jump is a positive indication of Oscar Health's market appeal amid growing competition in the healthcare insurance sector. Despite this membership growth, the company reported a loss of 53 cents per share, falling short of the anticipated consensus estimate of 61 cents.
Understanding the Financial Metrics
The medical loss ratio for the firm stood at 88.5%, contrasting with 84.6% from the previous year. This increase is a result of a rise in average market morbidity, which necessitated a $130 million increase in the net risk adjustment transfer accrual. However, favorable adjustments from prior periods partially mitigated some of these losses.
Selling, General and Administrative Expenses
Oscar Health’s SG&A expense ratio decreased to 17.5% from 19.0%. This reduction was primarily the result of improved fixed cost leverage and lower exchange fee rates, which indicates the company's focus on effective cost management. Nevertheless, the higher risk adjustment, as a percentage of premium, posed challenges that affected the bottom line.
Operational Loss Insights
The total loss from operations surged to $129.3 million, compared to a loss of $48.4 million the previous year. This increase reiterates the impact of changing market dynamics and the need for Oscar Health to adapt its operational strategies. The firm also reported an adjusted EBITDA loss of $101.5 million for Q3, starkly contrasting with a loss of $11.6 million a year earlier.
Future Guidance and Expectations
Despite the extensive losses, Oscar Health remains optimistic about its growth trajectory. The CEO, Mark Bertolini, expressed confidence in the company's pricing strategies and geographic expansion as essential components in regaining profitability by 2026. Furthermore, the company reaffirmed its fiscal 2025 sales guidance, projecting revenues between $12 billion to $12.2 billion.
Looking Ahead
For 2025, Oscar Health anticipates a medical loss ratio of 86%-87% and an SG&A expense ratio of 17.1%-17.6%, coupled with an operating loss ranging from $200 million to $300 million. These figures reflect ongoing efforts to enhance operational efficiency and manage expenses more effectively.
Market Response
At the time of publication, OSCR stock reflected a modest increase of 1.88%, trading at $17.32. Investor sentiment appears cautiously optimistic as the market digests the latest quarterly results and future projections.
Frequently Asked Questions
What was Oscar Health's revenue in the third quarter?
Oscar Health reported a revenue of approximately $2.99 billion for Q3.
How much did Oscar Health lose per share in Q3?
The company reported a loss of 53 cents per share for the third quarter.
What is Oscar Health's current membership count?
Total membership rose to roughly 2.12 million in the most recent quarter.
What are the projections for Oscar Health in fiscal 2025?
The company expects sales to range between $12 billion to $12.2 billion in fiscal 2025.
What steps is Oscar Health taking towards profitability?
The company is focusing on disciplined pricing, geographic expansion, and managing operational costs effectively.
